Filing Details
- Accession Number:
- 0001140361-16-080653
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-23 18:09:36
- Reporting Period:
- 2016-09-19
- Filing Date:
- 2016-09-23
- Accepted Time:
- 2016-09-23 18:09:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1128189 | Protokinetix Inc. | PKTX | Pharmaceutical Preparations (2834) | 943355026 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1516077 | Edward Clarence Smith | 1845 Country Road #214 St. Augustine FL 32084 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-09-19 | 37,263 | $0.06 | 2,510,226 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-09-19 | 50,000 | $0.06 | 2,560,226 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-09-20 | 5,000 | $0.06 | 2,565,226 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-09-20 | 112,500 | $0.06 | 2,667,726 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-09-21 | 4,100 | $0.06 | 2,681,826 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-09-21 | 10,300 | $0.06 | 2,692,126 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-09-21 | 25,000 | $0.06 | 2,717,126 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-09-22 | 10,000 | $0.06 | 2,727,126 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-09-22 | 20,000 | $0.06 | 2,747,126 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-09-23 | 24,400 | $0.06 | 2,771,526 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2016-09-23 | 22,700 | $0.06 | 2,794,226 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 43,820,500 | Direct | |
| Common Stock | 1,850,000 | Indirect | See footnote |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Option | $0.08 | 2019-12-31 | 5,000,000 | 5,000,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2019-12-31 | 5,000,000 | 5,000,000 | Direct |
Footnotes
- Shares held by the Clarence E. Smith Trust.
- Shares held in the reporting person's retirement account.
- Options granted pursuant to 2015 Stock Option and Stock Bonus Plan. On March 31, 2016, 1,250,000 shares vest; thereafter 1,250,000 vest each quarter.
Billionaire Hedge Funds
